Skip to main content
American Journal of Alzheimer's Disease and Other Dementias logoLink to American Journal of Alzheimer's Disease and Other Dementias
. 2020 Mar 30;35:1533317520915365. doi: 10.1177/1533317520915365

How Evidence-Based Practice (E3BP) Informs Speech-Language Pathology for Primary Progressive Aphasia

Leanne Ruggero 1,, Karen Croot 1,2, Lyndsey Nickels 1
PMCID: PMC10623930  PMID: 32223422

Abstract

Amelioration of communication impairment in primary progressive aphasia (PPA) is an area of clinical importance and current research. Speech-language pathologists (SLPs) have a range of skills and interventions to support communication in PPA; however, underrecognition of their role and low referral rates is an ongoing concern. The E3BP conceptualization of evidence-based practice comprises 3 components: research-based evidence, practice-based evidence, and informed patient preferences. Here, we will describe how evidence for managing the communication difficulties experienced by individuals with PPA exists at all 3 levels of the (E3BP) model, highlighting how this allows SLP interventions to be both evidence based and patient centered. We encourage health professionals to value and utilize the wide range of services that SLPs can offer when working with individuals with PPA, to educate, remediate everyday linguistic skills, increase daily participation, and maximize overall quality of life.

Keywords: primary progressive aphasia, evidence-based practice, evidence-based medicine, speech and language pathology, communication

Introduction

Dementias that are characterized predominantly by deterioration in communication skills are known collectively as “language-led dementias” or “primary progressive aphasia” (PPA). Primary progressive aphasia was first defined as “slowly progressive aphasia” by Mesulam, 1 (p592) and diagnosis requires insidious language decline. 2 Unlike amnestic forms of dementia, however, individuals with PPA in the initial to mid stages typically retain their nonlinguistic cognitive skills (including episodic memory) and often demonstrate acute awareness of their communication difficulties. 3,4

Primary progressive aphasia is not a disease per se, it is a range of heterogeneous clinical syndromes that do not have one underlying cause or pathology. As detailed by the current international diagnostic criteria, 2 there are 3 main and widely accepted clinical presentations: semantic variant, nonfluent/agrammatic variant, and logopenic variant. 2 All 3 variants typically have word-finding difficulties and impaired language production but differ in the nature of other linguistic impairments such as impaired language and object comprehension in semantic variant PPA and motor speech coordination impairments in nonfluent/agrammatic variant PPA. 5 In the later stages of the condition and as the neuropathology progresses, additional cognitive, behavioral, and motor symptoms emerge. 5

Primary progressive aphasia was previously described as the language presentation of frontotemporal dementia (FTD) with 2 clinical variants: a semantic and a nonfluent variant, until Gorno-Tempini and colleagues introduced the logopenic variant, and the need for consensus criteria for PPA diagnosis was recognized. 2,6,7 Since the development of the consensus criteria, however, we have come to understand that around 1 in 5 cases will remain difficult to categorize. 4 The changing clinical and pathological characterizations of PPA over the years have made it challenging for clinicians to keep current with information about PPA. 8,9 Notably, while some variants of PPA (semantic and nonfluent) typically arise from frontotemporal lobar degeneration (FTLD; note 1), others (logopenic variant) have Alzheimer’s pathology and are considered as atypically presenting Alzheimer’s disease. There are no studies establishing the prevalence of PPA per se, and calculations are muddied by the fact that most studies of FTD prevalence do not include the logopenic variant PPA (but do include motor and behavioral FTLD syndromes). However, Marshall and colleagues 4(citing 10,11 ) have suggested that PPA prevalence may be roughly in the order of 3 per 100 000. The fact that PPA has only been recognized since the early 1980s, and knowledge of the PPA variants, their clinical presentations and pathologies is still expanding, means that research into the role of speech-language pathologists (SLPs) and communication intervention for people with PPA is relatively in its infancy compared with stroke aphasia. 12

On a day-to-day basis, individuals with PPA will experience difficulties with communication in a variety of different contexts. 13 These might range from social situations to service transactions, from communicating clear financial and legal decisions to making basic needs or preferences understood. 14 Often individuals can maintain independence in these areas for longer with adequate and individualized support from health professionals such as SLPs. Even SLPs who have not had the benefit of specific training in PPA possess extensive knowledge of the assessment and management of communication, cognitive rehabilitation, activities of daily living, and designing person-centered interventions, and this makes them uniquely positioned to enhance the communication, coping, and quality of life of persons with PPA. 15 -17 Nevertheless, PPA referral rates to SLP services remain low 18 -20 and the role of SLPs working with communication in dementia syndromes is underrecognized. 21 Speech-language pathologists also provide vital support for swallowing difficulties in dementia syndromes (see the studies 22- 24 for further discussion of this issue); however, this article focuses on communication support.

Individuals with PPA may present to a wide range of care providers such as medical specialists, general practitioners, nurses and care workers, as well as SLPs. The aim of this article is to increase awareness among these health professionals that effective communication interventions are available to people with PPA and their families because SLPs are trained to develop intervention plans by triangulating 3 sources of evidence: research evidence, practice-based evidence, and the preferences of a fully informed patient. 25,26 This “multiple sources of evidence” approach is consistent with emerging emphases on patient-led care, quality of life, and patient-reported outcome measures in health-care systems globally. 15,21,27,28 Comprehensive reviews of treatment options in PPA are available elsewhere, and interested readers are encouraged to consult these for a summary of the latest research evidence. 29- 31

Provision of Communication Intervention for PPA

Historically, rehabilitative-style interventions have often not been offered to individuals with PPA, or indeed any dementia syndromes. 21,32 This has, first, been related to “the traditional therapeutic nihilism that frequently accompanies diagnosis of progressive disorders” that may be adopted when managing individuals with PPA. 33(p669) Second, referring parties continue to have low awareness of the value of SLP in positive management of the communication needs of people with PPA. 18 -20,34 In fact, the full extent of underrecognition and underreferral is unknown. Clearly, education for all health professionals on the role of the SLP in PPA management is of ongoing importance to ensure the best outcomes for these individuals. Indeed, some barriers to services for people with PPA have also come from within the SLP profession itself. 32 The first dementia position paper from the Royal College of Speech Language Therapists in the United Kingdom, for example, was as recent as 2005. It focused on memory difficulties in dementia 35 and did not address PPA at all. Subsequently, an Australian study in 2009 found that SLP respondents reported lack of confidence in dealing with PPA 18 and a US study in 2014 revealed that 43% of SLPs reported not being familiar with PPA at all. 34

Nowadays, a pressing amount of evidence exists to demonstrate that provision of communication intervention for PPA is valuable and critical for several reasons. First, PPA can be a younger onset dementia: individuals with PPA may be in their 40s or 50s, busy raising families and/or working. 36 In fact, research has shown that FTDs, including PPA, are associated with a substantial social and economic cost to individuals and their families. 37 Second, wide variation exists in survival and prognosis. Average survival has been reported as 10.6 years for people with semantic variant or 8 years for individuals with nonfluent variant following the onset of symptoms. 10 Language decline may be sufficiently slow in some cases that individuals live with relatively focal language deficits for over 10 years. 5 In other cases, however, the progression from purely linguistic to more generalized impairments can be markedly faster (note 2; see case described by Mahendra 38 ) For example, compare S1 and S5 in Croot and colleagues’ study, both of whom had initially similar presentations of nonfluent variant PPA: one deteriorated quickly after diagnosis and over a matter of months, while the other showed minimal change in mood and nonlanguage cognitive abilities over a period of years, resulting in considerable differences in their candidacy for interventions. 39 Third, many individuals with PPA have a heightened awareness of their communication impairments as their insight is typically intact, which can be associated with clinically significant distress and depression. 17,36,40 In summary, whether the language decline is rapidly progressive or painfully slow, each of these factors strongly warrants targeting lost linguistic skills and supporting important communicative interactions in people with PPA, enabling them to maximize their communication, autonomy, and quality of life for longer. 36,41 -43 Across all stages of this progression, many experts have suggested ways in which SLP support can benefit individuals with PPA and their families. This can include education, support, impairment-, or compensatory-directed interventions. 4,32,44- 47 Apart from directly targeting communication, of course, the application of SLP expertise to supporting individuals and families also benefits relationships, coping strategies, mental health and quality of life. 18,19

Moving forward, the words of Murray in 1998: “Professionals such as neurologists, neuropsychologists, and speech-language pathologists are encouraged to advocate for the provision of services to patients with PPA,” 33(p669) through to those of Cartwright more recently in 2015: “It is important that clinicians have the skills and resources available to instill hope and foster proactive coping strategies as a key component of therapeutic management [of PPA],” 17(p188) continue to ring true. Although the translation of this message into clinical services has been slow at times, this message is nonetheless being disseminated more and more, particularly in expert opinion pieces. 36,42,45,46 If we are mindful that people with PPA have specific needs that may not be fulfilled by services for amnestic dementias, the promotion of SLP interventions for individuals with dementia by professional associations is also promising. Practice statements now highlight that SLP interventions for individuals with dementia should be based on communicative strengths and weaknesses 48 and “promote and maintain [the] functional and social independence of people with dementia”. 49 (p7) Last, it is positive to see the popularity of learning opportunities and professional development workshops on PPA. Both the last 2 International Conferences on Frontotemporal Dementias have incorporated workshops to provide education on PPA to a wide range of clinical service providers, including SLPs, together with publicly available education resources. 50

Sources of Evidence for Communication Intervention in PPA

The E3BP Approach

Evidence-based medicine was first defined by Sackett and colleagues 51 and further elaborated as evidence-based practice for SLPs. 26,52 The latter is often described using the abbreviation E3BP, 26 making it explicit that there are 3 sources of evidence that are equally relevant in clinical decision-making. We define the 3 types of evidence here largely following Dollaghan and Lof. 26,52 Research evidence refers to the best available evidence from systematic research with high internal validity that applies to a given clinical question. 26 Practice-based evidence has also been previously described as “clinical expertise” 51(p71) and “evidence internal to clinical practice.” 26(p2) This refers to evidence which is collected in a clinical setting and which can have greater real-life application than is the case for some tightly controlled studies which generate research evidence. 52 Preferences of a fully informed patient refers to how clinicians develop a shared understanding of the “beliefs, preferences, hopes and fears” 26(p2) of individuals in their care so that these can be used to select interventions and set goals and therapeutic targets that the individuals will have confidence in and comply with. Dollaghan 26 discusses how best to obtain this information when working with individuals with communication difficulties, for example, via interview, proxy interview, or evidence triangulation.

Research-Based Evidence for SLP Services in PPA

Is there research evidence that SLPs can provide efficacious intervention to individuals with PPA? There are now numerous studies demonstrating the impact of interventions for PPA which focus directly on practicing and maintaining communication skills. These include systematic reviews (see studies 29 -31 for an overview) and an increasing number of single case-experimental design studies, both considered to provide high-quality evidence by the Oxford Centre for Evidence-Based Medicine, 53,54 as well as a growing body of case-controlled group studies. The majority of reports investigate lexical retrieval treatment, which is also described as word relearning. 30 These interventions train individuals with PPA to better retrieve a core vocabulary of personally relevant words. Many individuals benefit greatly from such training, which is evidenced by better retrieval of trained words than untrained words. Additionally, many of the individuals who participate in this type of intervention find it rewarding and positive. 55 While a few studies have demonstrated generalization to untrained items or contexts, there is no clear understanding yet of the mechanisms or factors which might promote generalization. 56 -58 Script training, which promotes rote learning of personally relevant statements and monologues, 59 and discourse training, which supports comprehension 60 and/or production of sentences and stories, 61,62 have also been shown to improve communication abilities in early to mid-disease for individuals with PPA. Although such interventions cannot prevent inevitable language deterioration, these studies provide research evidence that learning of practiced items and/or new strategies is indeed possible in PPA.

A number of other studies have found positive outcomes when supporting individuals to continue to engage in daily activities. Examples include facilitating comprehension and recall of, and discussion about, TV shows, 60 learning to write notes with accompanying photos in a smartphone to aid recall of shopping lists or to provide recounts of recent activities, 63,64 and using additional written and visual cues to aid in following recipes. 65 Improvements following such interventions are not only constrained to research settings but have resulted in spontaneous use of trained skills in novel everyday settings. 64

In addition to the options available on an individual basis, SLPs offer education, support, and/or conversation/communication groups to individuals with PPA and their families. Qualitative comments and survey data indicate that individuals with PPA and their families welcome education about PPA. 55,66 They also appreciate both direct psychosocial support and, indirectly, the opportunity to reduce isolation and meet others with the diagnosis 66 -68 that such groups provide. They also value the ability to practice communication skills in the naturalistic group setting and/or with new communication partners. 63 Family and communication partners can learn to better facilitate successful conversation. 55,68,69 Not only do participants report positively on many aspects of group intervention but there is additional evidence that these activities improve quality of life and/or confidence. 55,66 -68 As they typically include multiple components concurrently, it remains an open question which of the components of these group interventions contribute most to their positive outcomes.

Interventions can successfully be delivered via different modalities and platforms: face-to-face in the clinic, remotely using telephone or online platforms, by a trained primary communication partner at home, or by the individual with PPA working on home treatment tasks. 30

Practice-Based Evidence

Practice-based evidence can include expert opinions, in-practice data collection, case reports, or even family reports on the successes and challenges of interventions at home. Speech-language pathologist expert opinions and commentaries which advocate for particular interventions reflect the authors’ perceptions that those interventions have been effective in their clinical practice. For example, the majority of clinicians working with PPA in the United Kingdom reported that they predominantly use interventions which aim to increase participation in everyday goals and activities. 20,70 A number of other expert opinion papers or textbooks also advocate for this approach. Interventions that have been suggested to be supported by practice-based evidence include teaching conversation repair strategies and/or circumlocution (to help individuals communicate their message when they are unable to find the exact words they want), 46 communication partner training (where partners are taught how to communicate in ways which facilitate successful exchanges and reduce frustration), multimodal communication (where any modality such as writing, drawing, gesturing, and/or speaking can be used to convey a message), 62,71 and the use of communication aids (selecting symbols and/or pictures to convey a message). 44,46,71

Case studies of individuals with PPA who have demonstrated personally and clinically meaningful gains following intervention also provide practice-based evidence. For example, Murray describes a woman with PPA and her husband who experienced various communication benefits from multimodal communication, communication partner training, and use of an electronic communication aid over time, as well as social benefits from participation in an aphasia support group. 33

Lastly, the stories of those with PPA and their families regarding the effectiveness and usefulness of certain interventions is not to be overlooked as practice-based evidence. One lay author describes the significant impact a digital text to speech communication device had for her husband: “It gave Boyd his quality of life back again and he had confidence now to talk to people through the machine. It was definitely the right time for him to have it while he still had the cognitive skills to use it. He settled down again from being frustrated and agitated and was happier in himself for a while.” 16(p902) Reports such as these give SLPs knowledge about which interventions can benefit which individuals and can assist in determining whether a subsequent patient is similar enough to be likely to benefit from the same approach.

Preferences of Informed Patients

Integrating the preferences of informed patients is the third source of evidence in E3BP. Shared decision-making to align intervention approaches, goals, and specific items for therapy with patient preferences on a case-by-case basis is also consistent with a “patient-centered approach.” 21,72,73 Many individual factors may predispose a person with PPA to enjoy, benefit from, or engage with a particular intervention, including their degree of motivation, family support, choice of goals, current mood, cognitive resources, potential for learning and change, financial resources, and logistical issues such as transportation. 36,74,75 Taking these factors and preferences into account is likely to improve patients’ motivation and engagement with services, as well as their confidence and quality of life. 76,77

Once a patient has trialed an intervention, SLPs can consider questions such as: What did the patient think of the intervention? Is it something they feel they would commit to over a longer term? 26 Do the specific goals or items being targeted need to be adjusted? Indeed, given that individual responses to interventions cannot be guaranteed in advance, some PPA researchers are recommending short-term trials of treatment as indicators of who might be motivated and helped by treatment. 30,76 In addition, examining the preferences of patients should include consideration of their linguistic and sociocultural background so that interventions and therapy targets can be aligned and delivered in an affirmative and culturally congruent manner.

Triangulating Evidence Sources

E3BP integrates all three forms of evidence during clinical decision-making. 78 Once informed about the options, every individual will have different priorities for their communication and these need to be balanced against available research evidence and practice-based evidence. For example, research evidence tells us that word relearning interventions can be effective for core vocabulary as well as increasing confidence and participation. 30,79 We have also learned that some research participants are highly motivated to improve their speech and/or language impairment. For example, in our own research, a 64-year-old participant with logopenic variant PPA said, “You have to do things that are going to help you talk.…Finding the words is the best thing you can do.” Combining research evidence and patient preferences suggests that lexical retrieval treatment would be an excellent choice to support word-finding by the first individual, but combining practice-based evidence and patient preferences suggests it would be unsuitable for some others, despite the research evidence. 30,45,76,80 Similarly, research evidence tells us that introducing alternative modalities of communication earlier in the progression of the disease can relieve frustration and increase independence for some individuals. 16 In contrast, others may find that being introduced to compensatory-style interventions uncomfortably highlights the future reality that their language will decline. 36 Taking both the research evidence and the patient preferences into account, the SLP might decide not to introduce this type of intervention for the latter individuals.

Ultimately, the SLP needs to make a final decision about how to proceed, incorporating individual differences and all intervention options. Given that SLPs are trained to ensure that options are explained in an accessible and communication-friendly manner, individuals with communication impairments should be given every opportunity to engage in this decision-making process. The examples provided show how E3BP is a useful framework for integrating research and practice-based evidence, as well as the preferences of a fully formed patient, by weighting different types of evidence on a person-by-person basis. 81

Conclusion

Individuals with PPA experience devastating loss of communication skills, often while they are fully aware and are still in a very active phase of their lives. The effect of communication changes on quality of life, engagement in everyday activities, as well as families and relationships is extensive. Those of us working clinically with PPA need more research on the disease trajectory, treatments (effectiveness, candidacy, mechanisms underlying treatment gains, and generalization), compensation for communication difficulties (such as the forthcoming work being conducted in conversation partner training), 82 and a better understanding of perspective of individuals with PPA and what factors can promote well-being. 42

Speech-language pathologists can, however, already do a considerable amount to maximize day-to-day communication, participation, relationships, and quality of life in PPA. The 3 components of evidence-based practice—research-based evidence, practice-based evidence, and the preferences of informed patients—allow for a robust and broad range of evidence to be considered when supporting individuals with PPA with their communication, warranting early referrals to SLP services. It is crucial that all health professionals involved in the management of individuals with PPA at all levels of care, from diagnostic specialists to late-life residential care providers, are aware of the value of communication support and intervention for these individuals and their families.

Notes

1.

Frontotemporal lobar degeneration (FTLD) is a spectrum of neuropathologies associated with various clinical presentations including semantic variant primary progressive aphasia (PPA), nonfluent variant PPA, behavioral variant frontotemporal dementia, or motor syndromes including corticobasal syndrome and progressive supranuclear palsy. 10 Its progression is generally faster than that of Alzheimer’s disease. 83 Only the PPA variants are discussed in this paper (see the studies 9,84- 86 for further discussion of clinical presentations, prognosis, and management of FTLD).

2.

It is worth noting that the ability to assess whether solely linguistic versus more generalized cognitive functions are impaired is marred by the fact that many of the available and widely used assessments (such as the Mini Mental State Examination 87 or Addenbrooke’s Cognitive Examination III 88 ) rely heavily on language skills including comprehension, semantics, and expression. In such tests, the occurrence of word-finding difficulties, for example, can result in a reduced score on a memory or orientation subsection.

Footnotes

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding: The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Leanne Ruggero was supported by an Australian Government Research Training Program Scholarship and a Macquarie University Research Training Pathway Stipend Scholarship, and Lyndsey Nickels by an Australian Research Council Future Fellowship (FT120100102) during the preparation of this article.

References

  • 1. Mesulam MM. Slowly progressive aphasia without generalized dementia. Ann Neurol. 1982;11(6):592–598. doi:10.1002/ana.410110607. [DOI] [PubMed] [Google Scholar]
  • 2. Gorno-Tempini ML, Hillis AE, Weintraub S, et al. Classification of primary progressive aphasia and its variants. Neurology. 2011;76(11):1006–1014. doi:10.1212/WNL.0b013e31821103e6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Mesulam MM, Rogalski EJ, Wieneke C, et al. Primary progressive aphasia and the evolving neurology of the language network. Nat Rev Neurol. 2014;10(10):554–569. doi:10.1038/nrneurol.2014.159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Marshall CR, Hardy CJD, Volkmer A, et al. Primary progressive aphasia: a clinical approach. J Neurol. 2018;265(6):1474–1490. doi:10.1007/s00415-018-8762-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Mesulam MM. Primary progressive aphasia. Ann Neurol. 2001;49(4):425–432. doi:10.1002/ana.91. [PubMed] [Google Scholar]
  • 6. Gorno-Tempini M, Dronkers NF, Rankin KP, et al. Cognition and anatomy in three variants of primary progressive aphasia. Ann Neurol. 2004;55(3):335–346. doi:10.1016/j.cell.2005.10.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Croot K. Progressive language impairments: definitions, diagnoses, and prognoses. Aphasiology. 2009;23(2):302–326. doi:10.1080/02687030801942981 [Google Scholar]
  • 8. Leyton C, Ballard K. Primary progressive aphasia: conceptual evolution and challenges. Neurosci Neuroeconomics. 2016;5:9. doi:10.2147/nan.s102848. [Google Scholar]
  • 9. Hodges JR, Piguet O. Progress and challenges in frontotemporal dementia research: a 20-year review. J Alzheimer’s Dis. 2018;62(3):1467–1480. doi:10.3233/JAD-171087. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Coyle-Gilchrist ITS, Dick KM, Vázquez P, et al. Prevalence, characteristics, and survival of frontotemporal lobar degeneration syndromes. Neurology. 2016;86(18):1736–1743. doi:10.1212/WNL.0000000000002638. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Magnin E, Démonet J-F, Wallon D, et al. Primary progressive aphasia in the network of French Alzheimer plan memory centers. J Alzheimers Dis. 2016;54:1459–1471. doi:10.3233/JAD-160536. [DOI] [PubMed] [Google Scholar]
  • 12. Nickels L, Croot K. Clinical Perspectives on Primary Progressive Aphasia. Hove, United Kingdom: Psychology Press; 2015. doi:10.4324/9781315722702. [Google Scholar]
  • 13. Preiß D, Billette O V., Schneider A, Spotorno N, Nestor PJ. The atrophy pattern in Alzheimer-related PPA is more widespread than that of the frontotemporal lobar degeneration associated variants. NeuroImage Clin. 2019;24:101994. doi:10.1016/J.NICL.2019.101994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Sivasathiaseelan H, Marshall CR, Hardy CJD, Fox NC, Warren JD, Rossor MN. Aphasic binary reversals in patients with neurological disease as a barrier to clinical decision making. JAMA Neurol. 2018;76(2):234–235. doi:10.1001/jamaneurol.2018.3790. [DOI] [PubMed] [Google Scholar]
  • 15. Ellis C, Peach RK. Life satisfaction and aphasia: an integrative review with recommendations for future research. Aphasiology. 2017;31(6):631–642. doi:10.1080/02687038.2016.1154500. [Google Scholar]
  • 16. Rutherford S. Our journey with primary progressive aphasia. Aphasiology. 2014;28(8-9, SI):900–908. doi:10.1080/02687038.2014.930812. [Google Scholar]
  • 17. Cartwright J. Primary Progressive Aphasia: The Potential for Change [Doctoral Thesis]. Perth, Australia: University of Western Australia; 2015. https://research-repository.uwa.edu.au/en/publications/primary-progressive-aphasia-the-potential-for-change. Accessed January 20 2017. [Google Scholar]
  • 18. Taylor C, Kingma RM, Croot K, Nickels L. Speech pathology services for primary progressive aphasia: exploring an emerging area of practice. Aphasiology. 2009;23(2):161–174. doi:10.1080/02687030801943039. [Google Scholar]
  • 19. Volkmer A, Spector A, Warren JD, Beeke S. Speech and language therapy for primary progressive aphasia across the UK: a survey of current practice. Int J Lang Commun Disord. 2019;8. doi:10.1111/1460-6984.12495. [DOI] [PubMed] [Google Scholar]
  • 20. Volkmer A, Spector A, Warren JD, Beeke S. Speech and language therapy for primary progressive aphasia: referral patterns and barriers to service provision across the UK. Dementia. 2018:9. doi:10.1177/1471301218797240. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Bourgeois M, Brush J, Douglas N, Khayum R, Rogalski E. Will you still need me when I’m 64, or 84, or 104? The importance of speech-language pathologists in promoting the quality of life of aging adults in the United States into the future. Semin Speech Lang. 2016;37(03):185–200. doi:10.1055/s-0036-1583544. [DOI] [PubMed] [Google Scholar]
  • 22. Marin S de MC, Bertolucci PHF, Marin LF, et al. Swallowing in primary progressive aphasia. NeuroRehabilitation. 2016;38(1):85–92. doi:10.3233/NRE-151299. [DOI] [PubMed] [Google Scholar]
  • 23. Lewis C, Walterfang M, Velakoulis D, Vogel AP. A review: mealtime difficulties following frontotemporal lobar degeneration. Dement Geriatr Cogn Disord. 2018;46(5-6):285–297. doi:10.1159/000494210. [DOI] [PubMed] [Google Scholar]
  • 24. Alagiakrishnan K, Bhanji RA, Kurian M. Evaluation and management of oropharyngeal dysphagia in different types of dementia: a systematic review. Arch Gerontol Geriatr. 2013;56(1):1–9. doi:10.1016/J.ARCHGER.2012.04.011. [DOI] [PubMed] [Google Scholar]
  • 25. Robey R, Apel K, Dollaghan C, et al. American Speech-Language-Hearing Association. Report of the joint coordinating committee on evidence-based practice. 2004. https://www.asha.org/uploadedFiles/members/ebp/JCCEBPReport04.pdf. Accessed March 1, 2019.
  • 26. Dollaghan C. The Handbook for Evidence-Based Practice in Communication Disorders. In: Paul H, ed. Baltimore, MD: Brookes Publishing; 2007. [Google Scholar]
  • 27. Devlin NJ, Appleby J, Buxton M, et al. The King’s Fund. Getting the Most out of PROMs: Putting Health Outcomes at the Heart of NHS Decision Making. 2010. https://www.kingsfund.org.uk/publications/getting-most-out-proms. Accessed February 26, 2019.
  • 28. Williams K, Sansoni J, Morris D, Grootemaat P, Thompson C. Australian Commission on Safety and Quality in Health Care. Patient-Reported Outcome Measures: Literature Review. 2016. https://www.safetyandquality.gov.au/wp-content/uploads/2017/01/PROMs-Literature-Review-December-2016.pdf. Accessed February 26, 2019.
  • 29. Beales A, Whitworth A, Cartwright J. A review of lexical retrieval intervention in primary progressive aphasia and Alzheimer’s disease: mechanisms of change, generalisation, and cognition. Aphasiology. 2018:1–28. doi:10.1080/02687038.2018.1491192. 33012945 [Google Scholar]
  • 30. Croot K. Treatment for lexical retrieval impairments in primary progressive aphasia: a research update with implications for clinical practice. Semin Speech Lang. 2018;39(03):242–256. doi:10.1055/s-0038-1660783. [DOI] [PubMed] [Google Scholar]
  • 31. Volkmer A, Spector A, Meitanis V, Warren JD, Beeke S. Effects of functional communication interventions for people with primary progressive aphasia and their caregivers: a systematic review. Aging Ment Health. 2019;1–13. doi:10.1080/13607863.2019.1617246. [DOI] [PubMed] [Google Scholar]
  • 32. Khayum B, Wieneke C, Rogalski E, Robinson J, O’Hara M. Thinking outside the stroke: treating primary progressive aphasia (PPA). Perspect Gerontol. 2012;17(2):37–49. doi:10.1044/gero17.2.37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Murray LL. Longitudinal treatment of primary progressive aphasia: a case study. Aphasiology. 1998;12(7-8):651–672. doi:10.1080/02687039808249564. [Google Scholar]
  • 34. Wooley M. Roles of speech-language pathologists in aphasia therapy and rehabilitation as reported by practicing speech-language pathologists [Honor’s Thesis] . Oxford, MS: The University of Mississippi; 2014. http://thesis.honors.olemiss.edu/80/. Accessed March 16, 2017. [Google Scholar]
  • 35. Royal College of Speech & Language Therapists. Speech and Language Therapy Provision for People with Dementia. 2006. https://www.rcslt.org/-/media/Project/RCSLT/dementia-paper.pdf. Accessed February 28 2019.
  • 36. Duffy JR, McNeil MR. Primary progressive aphasia and apraxia of speech. In: Chapey R, ed. Language Intervention Strategies in Aphasia and Related Neurogenic Communication Disorders. 5th ed. Baltimore, MD: Lippincott Williams & Wilkins; 2008:543–564. [Google Scholar]
  • 37. Galvin JE, Howard DH, Denny SS, Dickinson S, Tatton N. The social and economic burden of frontotemporal degeneration. Neurology. 2017;89(20):2049–2056. doi:10.1212/WNL.0000000000004614. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. Mahendra N. The logopenic variant of primary progressive aphasia: effects on linguistic communication. Perspect Gerontol. 2012;17(2):50. doi:10.1044/gero17.2.50. [Google Scholar]
  • 39. Croot K, Raiser T, Taylor-Rubin C, et al. Lexical retrieval treatment in primary progressive aphasia: an investigation of treatment duration in a heterogeneous case series. Cortex. 2019;115:133–158. doi:10.1016/j.cortex.2019.01.009. [DOI] [PubMed] [Google Scholar]
  • 40. Medina J, Weintraub S. Depression in primary progressive aphasia. J Geriatr Psychiatry Neurol. 2007;20(3):153–160. doi:10.1177/0891988707303603. [DOI] [PubMed] [Google Scholar]
  • 41. Rapp B, Glucroft B. The benefits and protective effects of behavioural treatment for dysgraphia in a case of primary progressive aphasia. Aphasiology. 2009;23(2):236–265. doi:10.1080/02687030801943054. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42. Ruggero L, Nickels L, Croot K. Quality of life in primary progressive aphasia: what do we know and what can we do next? Aphasiology. 2019;33(5):498–519. doi:10.1080/02687038.2019.1568135. [Google Scholar]
  • 43. Jokel R, Graham NL, Rochon E, Leonard C. Word retrieval therapies in primary progressive aphasia. Aphasiology. 2014;28(8-9):1038–1068. doi:10.1080/02687038.2014.899306. [Google Scholar]
  • 44. Hinshelwood H, Henry M. Helping them hold on. ASHA Lead. 2016;21(10):44. doi:10.1044/leader.FTR1.21102016.44. [Google Scholar]
  • 45. Croot K, Nickels L, Laurence F, Manning M. Impairment and activity/participation-directed interventions in progressive language impairment: clinical and theoretical issues. Aphasiology. 2009;23(2):125–160. doi:10.1080/02687030801943179. [Google Scholar]
  • 46. Volkmer A. Assessment and Therapy for Language and Cognitive Communication Difficulties in Dementia and Other Progressive Diseases. Albury, UK: J&R Press; 2013. [Google Scholar]
  • 47. Low C, Podolsky L, Nesci E. Serving the underserved: primary progressive aphasia services in the life participation model. Poster presented at: Aphasia Access Conference; Orlando, FL; 2017. https://www.aphasia.ca/aphasia-access/. Accessed September 13, 2019. [Google Scholar]
  • 48. Royal College of Speech & Language Therapists. Speech and language therapy provision for people with dementia . 2014. https://www.rcslt.org/-/media/Project/RCSLT/people-living-with-dementia-paper.pdf. Accessed October 17, 2016.
  • 49. NHMRC Partnership Centre for Dealing with Cognitive and Related Functional Decline in Older People. Clinical practice guidelines and principles of care for people with dementia . 2016. http://sydney.edu.au/medicine/cdpc/resources/dementia-guidelines.php. Accessed February 28, 2019.
  • 50. International Conference on Frontotemporal Dementia. Aphasia resources . 2016-2018. https://ccd.edu.au/research/language/aphasia/. Accessed September 13, 2019.
  • 51. Sackett DL, Rosenberg WMC, Muir-Gray JA, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn’t. Br Med J. 1996;312(7023):71–72. doi:10.1136/bmj.312.7023.71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52. Lof GL. Science-based practice and the speech-language pathologist. Int J Speech Lang Pathol. 2011;13(3):189–196. doi:10.3109/17549507.2011.528801. [DOI] [PubMed] [Google Scholar]
  • 53. Howick J, Chalmers I, Glasziou P, et al. Oxford Centre for Evidence-Based Medicine. The 2011 Oxford CEBM levels of evidence (introductory document). 2016. https://www.cebm.net/index.aspx?o=5653. Accessed February 20, 2019.
  • 54. Best W, Ping Sze W, Edmundson A, Nickels L. What counts as evidence? Swimming against the tide: valuing both clinically informed experimentally controlled case series and randomized controlled trials in intervention research. Evid Based Commun Assess Interv. 2019;13(3):107–135. doi:10.1080/17489539.2019.1597444. [Google Scholar]
  • 55. Jokel R, Meltzer J, DR J, et al. Group intervention for individuals with primary progressive aphasia and their spouses: who comes first? J Commun Disord. 2017;66:51–64. doi:10.1016/j.jcomdis.2017.04.002. [DOI] [PubMed] [Google Scholar]
  • 56. Beales A, Cartwright J, Whitworth A, Panegyres PK. Exploring generalisation processes following lexical retrieval intervention in primary progressive aphasia. Int J Speech Lang Pathol. 2016;18(3):299–314. doi:10.3109/17549507.2016.1151936. [DOI] [PubMed] [Google Scholar]
  • 57. Newhart M, Davis C, Kannan V, Heidler-Gary J, Cloutman L, Hillis AE. Therapy for naming deficits in two variants of primary progressive aphasia. Aphasiology. 2009;23(7-8):823–834. doi:10.1080/02687030802661762. [Google Scholar]
  • 58. Savage SA, Piguet O, Hodges JR. Giving words new life: generalization of word retraining outcomes in semantic dementia. J Alzheimers Dis. 2014;40(2):309–317. doi:10.3233/JAD-131826. [DOI] [PubMed] [Google Scholar]
  • 59. Henry ML, Hubbard HI, Grasso SM, et al. Retraining speech production and fluency in non-fluent/agrammatic primary progressive aphasia. Brain. 2018;141(6):1799–1814. doi:10.1093/brain/awy101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60. Cartwright J, Elliott KAE. Promoting strategic television viewing in the context of progressive language impairment. Aphasiology. 2009;23(2):266–285. doi:10.1080/02687030801942932. [Google Scholar]
  • 61. Whitworth A, Cartwright J, Beales A, Leitão S, Panegyres PK, Kane R. Taking words to a new level: a preliminary investigation of discourse intervention in primary progressive aphasia. Aphasiology. 2018;32(11):1284–1309. doi:10.1080/02687038.2017.1390543. [Google Scholar]
  • 62. Wong SB, Anand R, Chapman SB, Rackley A, Zientz J. When nouns and verbs degrade: facilitating communication in semantic dementia. Aphasiology. 2009;23(2):286–301. doi:10.1080/02687030801943112. [Google Scholar]
  • 63. Mooney A, Bedrick S, Noethe G, Spaulding S, Fried-Oken M. Mobile technology to support lexical retrieval during activity retell in primary progressive aphasia. Aphasiology. 2018;32(6):666–692. doi:10.1080/02687038.2018.1447640. [Google Scholar]
  • 64. Bier N, Paquette G, Macoir J. Smartphone for smart living: using new technologies to cope with everyday limitations in semantic dementia. Neuropsychol Rehabil. 2018;28(5):734–754. doi:10.1080/09602011.2015.1094395. [DOI] [PubMed] [Google Scholar]
  • 65. Bier N, Macoir J, Joubert S, et al. Cooking “shrimp à la Créole”: a pilot study of an ecological rehabilitation in semantic dementia. Neuropsychol Rehabil. 2011;21(4):455–483. doi:10.1080/09602011.2011.580614. [DOI] [PubMed] [Google Scholar]
  • 66. Morhardt DJ, O’Hara MC, Zachrich K, Wieneke C, Rogalski EJ. Development of a psycho-educational support program for individuals with primary progressive aphasia and their care-partners. Dementia. 2019;18(4):1310–1327. doi:10.1177/1471301217699675. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67. Taylor-Rubin C, Azizi L, Croot K, Nickels L. Primary progressive aphasia education and support groups: a clinical evaluation. Am J Alzheimer’s Dis Other Dementias. 2019. ; XX(XX):XX-XX. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68. Mooney A, Beale N, Fried-Oken M. Group communication treatment for individuals with PPA and their partners. Semin Speech Lang. 2018;39(03):257–269. doi:10.1055/s-0038-1660784. [DOI] [PubMed] [Google Scholar]
  • 69. Kim E, Figeys M, Hubbard H, Wilson C. The impact of aphasia camp participation on quality of life: a primary progressive aphasia perspective. Semin Speech Lang. 2018;39(03):270–283. doi:10.1055/s-0038-1660785. [DOI] [PubMed] [Google Scholar]
  • 70. Kindell J, Sage K, Cruice M. Supporting communication in semantic dementia: clinical consensus from expert practitioners. Qual Ageing Older Adults. 2015;16(3):153–164. doi:10.1108/QAOA-08-2014-0016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71. Rogers MA, Alarcon NB. Dissolution of spoken language in primary progressive aphasia. Aphasiology. 1998;12(7):635–650. doi:10.1080/02687039808249563. [Google Scholar]
  • 72. Hickson L. Evidence-based practice in adult audiologic rehabilitation. In: Montana J, Spitzer J, eds. Adult Audiologic Rehabilitation. 2nd ed. San Diego, CA: Plural Publisher; 2014:401–414. [Google Scholar]
  • 73. Foster AM, Worrall LE, Rose ML, O’Halloran R. Turning the tide: putting acute aphasia management back on the agenda through evidence-based practice. Aphasiology. 2013;27(4):420–443. doi:10.1080/02687038.2013.770818. [Google Scholar]
  • 74. O’Connor CM, Clemson L, Hornberger M, et al. Longitudinal change in everyday function and behavioral symptoms in frontotemporal dementia. Neurol Clin Pract. 2016;6(5):419–428. doi:10.1212/CPJ.0000000000000264. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75. Singh TD, Duffy JR, Strand EA, Machulda MM, Whitwell JL, Josephs KA. Neuropsychiatric symptoms in primary progressive aphasia and apraxia of speech. Dement Geriatr Cogn Disord. 2015;39(3-4):228–238. doi:10.1159/000369062. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76. Taylor-Rubin C, Croot K, Nickels L. Adherence to lexical retrieval treatment in Primary progressive aphasia and implications for candidacy. Aphasiology. 2019;33(10):1182–1201. doi:10.1080/02687038.2019.1621031. [Google Scholar]
  • 77. Worrall LE, Holland A. Editorial: quality of life in aphasia. Aphasiology. 2003;17(4):329–332. doi:10.1080/02687030244000699. [Google Scholar]
  • 78. Spring B. Evidence based practice in psychology: what it is, why it matters; what you need to know. J Clin Psychol. 2007;63(7):611–631. doi:10.1002/jclp.20373. [DOI] [PubMed] [Google Scholar]
  • 79. Rogalski EJ, Saxon M, McKenna H, et al. Communication bridge: a pilot feasibility study of internet-based speech–language therapy for individuals with progressive aphasia. Alzheimer’s Dement Transl Res Clin Interv. 2016;2(4):213–221. doi:10.1016/j.trci.2016.08.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80. Graham KS, Patterson K, Pratt KH, Hodges JR. Relearning and subsequent forgetting of semantic category exemplars in a case of semantic dementia. Neuropsychology. 1999;13(3):359–380. doi:10.1037/0894-4105.13.3.359. [DOI] [PubMed] [Google Scholar]
  • 81. Haynes RB. Clinical expertise in the era of evidence-based medicine and patient choice. Evid Based Med. 2002;7(2):36–38. doi:10.1136/ebm.7.2.36. [PubMed] [Google Scholar]
  • 82. Volkmer A, Spector A, Warren JD, Beeke S. The ‘Better Conversations With Primary Progressive Aphasia (BCPPA)’ program for people with PPA (Primary Progressive Aphasia): protocol for a randomised controlled pilot study. Pilot Feasibility Stud. 2018;4(1):158. doi:10.1186/s40814-018-0349-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83. Chow TW, Hynan LS, Lipton AM. MMSE scores decline at a greater rate in frontotemporal degeneration than in AD. Dement Geriatr Cogn Disord. 2006;22(3):194–199. doi:10.1159/000094870. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84. Rascovsky K, Salmon DP, Lipton AM, et al. Rate of progression differs in frontotemporal dementia and Alzheimer disease. Neurology. 2005;65(3):397–403. doi:10.1212/01.wnl.0000171343.43314.6e. [DOI] [PubMed] [Google Scholar]
  • 85. Rosness TA, Engedal K, Chemali Z. Frontotemporal dementia: an updated clinician’s guide. J Geriatr Psychiatry Neurol. 2016;29(5):271–280. doi:10.1177/0891988716654986. [DOI] [PubMed] [Google Scholar]
  • 86. Karageorgiou E, Miller B. Frontotemporal lobar degeneration: a clinical approach. Semin Neurol. 2014;34(02):189–201. doi:10.1055/s-0034-1381735. [DOI] [PubMed] [Google Scholar]
  • 87. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–198. doi:10.1016/0022-3956(75)90026-6. [DOI] [PubMed] [Google Scholar]
  • 88. Hsieh S, Schubert S, Hoon C, Mioshi E, Hodges JR. Validation of the Addenbrooke’s cognitive examination III in frontotemporal dementia and Alzheimer’s disease. Dement Geriatr Cogn Disord. 2013;36(3-4):242–250. doi:10.1159/000351671. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Alzheimer's Disease and Other Dementias are provided here courtesy of SAGE Publications

RESOURCES